amfAR, The Foundation for AIDS Research

amfAR’s public policy office in Washington, D.C., educates policy makers, the media, and the public about evidence-based policies to address HIV/AIDS in the U.S. and around the world.


A Hidden and Growing Epidemic

Over 3 million Americans have hepatitis C virus (HCV), and an estimated 75% are undiagnosed. But the CDC’s HCV surveillance system is seriously underfunded.

PEPFAR database rotator.jpg

amfAR Database Illuminates PEPFAR Programs and Priorities

New database enables users to access and understand PEPFAR programs and priorities at a deeper level than was previously possible.

The Exchange - End the Ban on syringe exchanges rotator image

The Case for Syringe Exchange

amfAR’s issue briefs and short films make a convincing case for ending the ban on federal funding for syringe services programs.


Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future

amfAR’s new Issue Brief warns of the free trade agreement’s potentially damaging effects on global public health.

Women and HIV/AIDS: Fast-Tracking the U.S. and Global Response. Learn more and RSVP now.

amfAR Capitol Hill Conference

Women and HIV/AIDS: Fast-Tracking the U.S. and Global Response.


An Essential Tool to Fight HIV and Health Disparities

Black Americans in states not expanding Medicaid are more than six times as likely to be diagnosed with HIV.